A carregar...
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics
BACKGROUND: Although hydrochlorothiazide (HCTZ) is a well‐established first‐line antihypertensive in the United States, <50% of HCTZ treated patients achieve blood pressure (BP) control. Thus, identifying biomarkers that could predict the BP response to HCTZ is critically important. In this study...
Na minha lista:
Publicado no: | J Am Heart Assoc |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5778957/ https://ncbi.nlm.nih.gov/pubmed/29288159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006656 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|